A sensitive and entirely automated solid-phase extraction/liquid chromatography/electrospray ionization tandem mass spectrometric (SPE/LC/ESI-MS/MS) method was developed and validated for the determination of eserine N -oxide (ENO), a cholinesterase inhibitor-like physostigmine in human plasma, for
Quantification of asenapine and three metabolites in human plasma using liquid chromatography–tandem mass spectrometry with automated solid-phase extraction: application to a phase I clinical trial with asenapine in healthy male subjects
✍ Scribed by Theo de Boer; Erik Meulman; Henri Meijering; Jaap Wieling; Peter Dogterom; Holger Lass
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 362 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0269-3879
- DOI
- 10.1002/bmc.1640
No coin nor oath required. For personal study only.
✦ Synopsis
ABSTRACT
The development and validation of methods for determining concentrations of the antipsychotic drug asenapine (ASE) and three of its metabolites [N‐desmethylasenapine (DMA), asenapine‐N^+^‐glucuronide (ASG) and 11‐O‐sulfate‐asenapine (OSA)] in human plasma using LC‐MS/MS with automated solid‐phase extraction is described. The three assessment methods in human plasma were found to be acceptable for quantification in the ranges 0.0250–20.0 ng/mL (ASE), 0.0500–20.0 ng/mL (DMA and OSA) and 0.250–50.0 ng/mL (ASG). Copyright © 2011 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES